Zealand Pharma A/s Stock
€41.05
Your prediction
Financial data and news for Zealand
sharewise wants to provide you with the best news and tools for Zealand, so we directly link to the best financial data sources.
Financials
News
HICL Infrastructure Targets 10%+ Returns With Self-Funded Growth Strategy
Key Points
- Interested in HICL Infrastructure PLC? Here are five stocks we like better.
- HICL Infrastructure is targeting 10%+ medium-term total returns by shifting more of its portfolio toward
Merlin, Inc. Common Stock Q1 Earnings Call Highlights
Key Points
- Interested in Merlin, Inc. Common Stock? Here are five stocks we like better.
- Merlin used its first public-company earnings call to spotlight its autonomous flight strategy
SAB Biotherapeutics Q1 Earnings Call Highlights
SAB Biotherapeutics (NASDAQ:SABS) said its lead type 1 diabetes candidate, SAB-142, remains on track in a registrational Phase 2b trial, as the
2 Missions, 3 Launches, and Up to $300 Million for Rocket Lab
Rocket Lab (NASDAQ: RKLB) is on a roll -- not that you could tell from the stock price.
Shares of the tiny, U.S.- and New Zealand-based Space Exploration Technologies lookalike are down 32% so far
Why Rocket Lab Stock Went to the Moon Today
Rocket star Rocket Lab (NASDAQ: RKLB) is making headlines again this morning, after completing yet another satellite launch for Synspective over the weekend. (They also delayed a launch for iQPS,
A Weight-Loss Rival Just Crashed 23%. Why That's Great News for Eli Lilly and Novo Nordisk.
The GLP weight-loss space has become increasingly competitive as new players have entered what many believe is a game-changing new market that’s still in the early innings.
But getting in the game